Suppr超能文献

基于MEDPAR数据集,根据手术量或临床结果对医院进行经皮冠状动脉介入治疗认证:对患者死亡率、成本和治疗可及性的影响

Accreditation of hospitals for percutaneous coronary intervention on the basis of volume or clinical outcome using MEDPAR data sets: effect on patient mortality, cost and treatment accessibility.

作者信息

Ellis S G, Dushman-Ellis S J

机构信息

The Cleveland Clinic Foundation, 9500 Euclid Avenue, F-25, Cleveland, OH 44195, USA.

出版信息

J Invasive Cardiol. 2000 Sep;12(9):464-71.

Abstract

BACKGROUND

The risk of major complications of percutaneous coronary revascularization (PCR) is modestly lower in high-volume as opposed to low-volume hospitals, but this is not a consistent finding for all hospitals. There are also limitations comparing risk-adjusted outcomes between hospitals. We sought to ascertain the effect of credentialing hospitals for PCR, either on the basis of procedural volume or outcome, on clinical outcome, cost and accessibility to treatment, in states of varied population density.

METHODS

We evaluated Medicare administrative data sets for all PCRs performed in 9 states during 1994Eth 1995. Based upon volume- and risk-adjusted in-hospital mortality during 1994, hospitals were OaccreditedO using varying volume and outcome thresholds, and the effect of accreditation using these thresholds was ascertained by analysis of 1995 outcomes. Sensitivity analyses were performed to assess the effect of altered assumptions.

RESULTS

During 1994, one hundred and thirty-three hospitals performed 34,879 PCRs in Medicare patients, with an overall mortality of 1.36%. If credentialing were performed based upon 1994 volumes, a sizable clinical benefit could be expected only if large numbers of catheterization laboratories were OclosedO, e.g., if laboratories with < 200Eth 300 Medicare cases/year (< 400Eth 900 total cases) were OclosedO, mortality would be expected to decrease to 0.17Eth 1.07% (maximum and minimum effect). Costs could be minimized by closing laboratories with < 100 Medicare cases/year (best case scenario, $512Eth $905/patient). Such laboratory closures would require transfer to hospitals > 50 miles distant in 6Eth 38% of patients, but as many as 18Eth 94% of patients in low-density states. If credentialing were done on the basis of 1994 adjusted mortality, a somewhat lesser reduction of risk of death (best case scenario, 0.93%), but little improvement in cost, could be expected.

CONCLUSIONS

If generalizable, these data suggest that to achieve a sizable reduction in procedure-related mortality by hospital-based credentialing, large numbers of catheterization laboratories would need to be closed and patient access to care would be adversely impacted. Cost savings of a very considerable magnitude may be more readily achieved.

摘要

背景

与低手术量医院相比,高手术量医院经皮冠状动脉血运重建术(PCR)的主要并发症风险略低,但并非所有医院都有这一一致发现。比较医院间风险调整后的结果也存在局限性。我们试图确定,在不同人口密度的州,基于手术量或结果对医院进行PCR资质认证,对临床结果、成本和治疗可及性的影响。

方法

我们评估了1994年至1995年期间9个州所有PCR手术的医疗保险管理数据集。根据1994年的手术量和风险调整后的住院死亡率,使用不同的手术量和结果阈值对医院进行“认证”,并通过分析1995年的结果来确定使用这些阈值进行认证的效果。进行敏感性分析以评估假设改变的影响。

结果

1994年,133家医院为医疗保险患者进行了34879例PCR手术,总体死亡率为1.36%。如果根据1994年的手术量进行资质认证,只有在大量导管实验室“关闭”的情况下,才有望获得可观的临床益处,例如,如果关闭每年<200至300例医疗保险病例(<400至900例总病例)的实验室,死亡率预计将降至0.17%至1.07%(最大和最小效果)。通过关闭每年<100例医疗保险病例的实验室,成本可降至最低(最佳情况,每位患者512至905美元)。这种实验室关闭将需要6%至38%的患者转诊到距离>50英里的医院,但在低密度州,多达18%至94%的患者需要转诊。如果根据1994年调整后的死亡率进行资质认证,预计死亡风险的降低幅度会稍小一些(最佳情况为0.93%),但成本改善不大。

结论

如果这些数据具有普遍性,表明通过基于医院的资质认证要实现与手术相关死亡率的大幅降低,需要关闭大量导管实验室,并且患者获得医疗服务的机会将受到不利影响。可能更容易实现非常可观的成本节约。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验